Rare Diseases Consulting
Specialized strategic advisory for orphan and ultra-rare diseases from drug development to market access and patient engagement.
The Rare Diseases Consulting portfolio offers specialized strategic advising services to help pharmaceutical, biotechnology, and healthcare companies deal with the difficult needs of treating orphan and ultra-rare diseases. Our team helps customers in every manner possible, including through rare illness market research, epidemiological modeling, orphan drug development, regulatory pathway assessments, and pricing and reimbursement development.
Key Highlights
We help companies optimize their pipeline selection process and gain faster regulatory approvals and better market access results through patient path mapping and stakeholder engagement methods.
Our expertise includes advocacy landscape assessments and real-world proof data integration to support market access and reimbursement strategies.
We know how to make gene and cell therapies, run specialist distribution systems, and build value-based contracting models.
Our services help companies stay successful in the market while serving important patient needs in advanced therapy areas.
What's Included
- Rare disease market research and opportunity assessment
- Epidemiological modeling and patient population analysis
- Orphan drug development strategy
- Regulatory pathway assessment and optimization
- Pricing and reimbursement strategy development
- Patient pathway mapping and journey analysis
- Stakeholder engagement and advocacy landscape assessment
- Real-world evidence integration and outcomes research
- Gene and cell therapy commercialization strategy
- Specialty distribution and access program design
- Value-based contracting model development